Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Olaparib
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
PEGASPARGASE
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(68)
PREDNISONE TABLETS
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(68)
(+)-VINCRISTINE
Gastrointestinal Carcinoid Tumor
National Cancer Institute (NCI)
P3
BB
(68)
Cediranib
Adenocarcinoma of the Rectum
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
MALT Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Nodal Marginal Zone B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Prostate Adenocarcinoma
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Recurrent Childhood Ependymoma
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Refractory Anemia With Excess Blasts
National Cancer Institute (NCI)
P2
BB
(68)
Cediranib
Splenic Marginal Zone Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Cyclophosphamide
Small Intestine Cancer
National Cancer Institute (NCI)
P2
BB
(68)
ETOPOSIDE
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
BB
(68)
ETOPOSIDE
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Inno-206
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Inno-206
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Irinotecan
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)
P2
BB
(68)
PREDNISONE TABLETS
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
PREDNISONE TABLETS
Haematological Malignancy
National Cancer Institute (NCI)
P2
BB
(68)
PREDNISONE TABLETS
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Showing 201 to 225 of 4,361 assets
Previous
Page 9 of 175
Next